Harvard Bioscience Inc - Company Profile
Powered by 
All the sales intelligence you need on Harvard Bioscience Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Harvard Bioscience Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Harvard Bioscience Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures, and markets instruments, consumables, systems, and software. The company’s products include spectrophotometers, plate readers, gel electrophoresis equipment, amino acid analyzers, electroporation and electrofusion instruments, wireless monitors, data acquisition and analysis products and software, and syringe pump and peristaltic pumps, among others. It also provides data analysis, training, and installation services. Harvard Bioscience serves research scientists at pharmaceutical and biotechnology companies, hospitals, universities, government laboratories, and contract research organizations. It markets products directly in the US, the UK, Germany, France, Sweden, Canada, Italy, Spain and China; and also through a network of distributors in other countries. Harvard Bioscience is headquartered in Holliston, Massachusetts, the US.
Headquarters
United States of America
Address
84 October Hill Rd, Holliston, Massachusetts, 01746
Website
www.harvardbioscience.com
Telephone
1 508 8938999
No of Employees
330
Industry
Medical Equipment
Ticker Symbol & Exchange
HBIO (NASD)
Revenue (2024)
$94.1M
-16.1%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-263.3%
(2024 vs 2023)
Market Cap*
$31.1M
Net Profit Margin (2024)
XYZ
-333.6%
(2024 vs 2023)
* As of and is in US$
Harvard Bioscience Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Cellular and Molecular Technologies (CMT): | Data Analysis | Harvard Apparatus |
| Syringe Pump | Training | DSI |
| Surgical Products | Installation | Ponemah |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In September, the company entered into an agreement with Etisense for supply and distribution of DECRO miniature telemetry Jacket Platform for preclinical research. |
| 2022 | New Products/Services | In April, the company has introduced Smart Study, a next generation Innovation Technology Inhalation System which aims at improving Precision, reducing costs and improved productivity for preclinical researchers. |
| 2020 | New Products/Services | In March, the company launched Accumulated Inhaled Aerosol Technology to aid in the fight against COVID-19. |
Competitor Comparison
| Key Parameters | Harvard Bioscience Inc | Thermo Fisher Scientific Inc | Danaher Corp | Becton Dickinson and Co | Lonza Group Ltd |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | Switzerland |
| City | Holliston | Waltham | Washington | Franklin Lakes | Basel |
| State/Province | Massachusetts | Massachusetts | WashingtonD.C. | New Jersey | - |
| No. of Employees | 330 | 125,000 | 61,000 | 72,000 | 19,771 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| John Duke | Director; Chief Executive Officer; President | Executive Board | 2025 | 55 |
| Mark Frost | Treasurer; Interim Chief Financial Officer | Senior Management | 2025 | 62 |
| Nitya Shetty | Vice President - Global Research and Development | Senior Management | 2021 | - |
| Diane Houston | Vice President - Global IT | Senior Management | - | - |
| Ryan Wallace | Vice President - Global Sales | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer